-
-
-
-
-
-
-
Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c
-
-
-
-
-
-
-
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
-
-
-
-
-
-
-
Allarity Therapeutics Reports Second Quarter 2022 Financial Results, Provides Recent Operational Highlights, and Regains Compliance with NASDAQ Listing Requirements
-
-
-
-
-
-
-
Allarity Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
-
1,198,729 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

